Despite Brexit uncertainty and travel restrictions that have just been imposed on the UK, the country’s generics industry is not expected to suffer major disruptions.
As the UK approaches the end of 2020 without clarity over future trading arrangements with the EU, at the same time as newly-imposed travel restrictions put further pressure on the supply chain, the country’s generics industry is nevertheless not expected to suffer major disruptions, according to the British Generic Manufacturers Association.
Negotiations between the UK and the EU are continuing over post-Brexit trading arrangements that are due to come into force...
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
